In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
Clinical trial NCT04921241 · COMPLETED
Trial details
- NCT number
- NCT04921241
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-08
- Primary completion
- 2022-09-28
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.